Experts express concern about use of Stanislaw Burzynski’s ‘antineoplastons’ for cancer treatment
A group of medical, scientific and policy experts joined forces with the Center for Inquiry (CFI) in sending a letter to Food and Drug Administration (FDA) Commissioner, Margaret A. Hamburg, MD expressing concern More...